Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19)
vaccines might reduce viral load in breakthrough infection and thereby further …

The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in preventing
disease and reducing viral loads of breakthrough infections (BTIs) has been decreasing…

Treatment of bacterial infections currently focuses on choosing an antibiotic that matches a
pathogen’s susceptibility, with less attention paid to the risk that even susceptibility-matched …

Background Diabetes mellitus and hypertension are risk factors for acute kidney injury (AKI).
Whether estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (ACR…

Background Waning of protection against infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) conferred by 2 doses of the BNT162b2 vaccine begins shortly …

Background Acute kidney injury (AKI) is a serious global public health problem. We aimed
to quantify the risk of AKI associated with estimated glomerular filtration rate (eGFR), …

Background: There is insufficient evidence regarding the magnitude and durability of
protection conferred by a combined effect of naturally acquired immunity after SARS-CoV-2 …

The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of breakthrough
infections (BTIs), an important factor affecting infectiousness. This viral-load protective effect has …

Background Computational models on the basis of deep neural networks are increasingly
used to analyze health care data. However, the efficacy of traditional computational models in …

Mass vaccination has the potential to curb the current COVID-19 pandemic by protecting
individuals who have been vaccinated against the disease and possibly lowering the likelihood …